Agios Pharmaceuticals
Agios Pharmaceuticals
Employees:
330
Market Cap:
$3.52 billion
Revenue:
$43.01 million
5 Year Trend:
11.3%
Net Income:
$-285.21 million
Stock:
AGIO

Agios Pharmaceuticals is a public American pharmaceutical company focused on developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism via the growth factor pathway. Among the proteins under investigation by the company are IDH1 and IDH2. Wikipedia

Agios Pharmaceuticals
Are you from Agios Pharmaceuticals?

Agios Pharmaceuticals is a public American pharmaceutical company focused on developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism via the growth factor pathway. Among the proteins under investigation by the company are IDH1 and IDH2. Wikipedia

Employees:
330
Market Cap:
$3.52 billion
Revenue:
$43.01 million
5 Year Trend:
11.3%
Net Income:
$-285.21 million
Stock:
AGIO

27 jobs at Agios Pharmaceuticals

Jobs in